Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
Author(s) -
Natasha Halasa,
Samantha M. Olson,
Mary Allen Staat,
Margaret M. Newhams,
Ashley M. Price,
Pia S. Pannaraj,
Julie A. Boom,
Leila C. Sahni,
Kathleen Chiotos,
Melissa A. Cameron,
Katherine Bline,
Charlotte V. Hobbs,
Aline B. Maddux,
Bria M. Coates,
Kelly Michelson,
Sabrina M. Heidemann,
Katherine Irby,
Ryan A. Nofziger,
Elizabeth H. Mack,
Laura Smallcomb,
Stephanie P. Schwartz,
Tracie C. Walker,
Shira J. Gertz,
Jennifer E. Schuster,
Satoshi Kamidani,
Keiko M. Tarquinio,
Samina Bhumbra,
Mia Maamari,
Janet R. Hume,
Hillary Crandall,
Emily R. Levy,
Matt S. Zinter,
Tamara T. Bradford,
Heidi R. Flori,
Melissa L. Cullimore,
Michele Kong,
Natalie Z. Cvijanovich,
Suzanne M. Gilboa,
Kara N.D. Polen,
Angela P. Campbell,
Adrienne G. Randolph,
Manish M. Patel
Publication year - 2022
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2204399
Subject(s) - covid-19 , vaccination , medicine , pediatrics , virology , outbreak , infectious disease (medical specialty) , disease
Infants younger than 6 months of age are at high risk for complications of coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental transfer of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after maternal Covid-19 vaccination may confer protection against Covid-19 in infants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom